Blog
RSS FeedPosted by Michael Wonder on 10 Sep 2018
SMC - September 2018 decisions
10 September 2018 - The Scottish Medicines Consortium, has today published advice accepting four new medicines for use by NHSScotland. ...
Posted by Michael Wonder on 10 Sep 2018
Drug firms try to rip off taxpayers, says Matt Hancock
8 September 2018 - Pharmaceutical companies are trying to “rip off taxpayers” and big business must be more socially responsible, ...
Posted by Michael Wonder on 10 Sep 2018
Roche faces UK pricing row over multiple sclerosis drug Ocrevus
10 September 2018 - Roche faces a fresh row over drug pricing in Britain, following a decision by the body responsible ...
Posted by Michael Wonder on 10 Sep 2018
MS Society launches petition against NICE’s rejection of Ocrevus
10 september 2018 - The MS Society has launched a petition imploring the National Institute for Health and Care Excellence, ...
Posted by Michael Wonder on 09 Sep 2018
It's not just the EpiPen. Canada had 25 new drug shortages this week alone
8 September 2018 - Migraine and Parkinson's disease drugs and anesthetic among treatments added to drug shortage site. ...
Posted by Michael Wonder on 06 Sep 2018
Is it time for a review of the content in PBAC Public Summary Documents?
7 September 2018 - Important content is either not reported or not reported in a consistent manner. ...
Posted by Michael Wonder on 06 Sep 2018
We can make medicine affordable without the damage Pharmacare will cause Canadians
5 September 2018 - Governments should have public plans match the superior coverage offered in private drug plans and cover more ...
Posted by Michael Wonder on 06 Sep 2018
Health insurance funds to help government sell premium hikes
6 September 2018 - Health funds will provide an unprecedented level of detail with their applications to raise premiums next ...
Posted by Michael Wonder on 06 Sep 2018
UK lags behind most of Europe in access to biologics for patients with rheumatoid arthritis
4 September 2018 - Global leader in biosimilars, Celltrion Healthcare announces support for the easing of initiation boundaries for biologics that ...
Posted by Michael Wonder on 06 Sep 2018
Proposal on the funding of infliximab, rituximab and tocilizumab
6 September 2018 - PHARMAC is proposing to change how three hospital medicines are managed within the Pharmaceutical Schedule. ...
Posted by Michael Wonder on 06 Sep 2018
Approval of multi-product funding agreement with Novartis
6 September 2018 - PHARMAC is pleased to announce a major funding package involving ten medicines in seven key therapy ...
Posted by Michael Wonder on 06 Sep 2018
New agreement makes more medicines available to treat range of health conditions
6 September 2018 - Up to 50,000 New Zealanders per year will benefit from a new multiproduct agreement PHARMAC has ...
Posted by Michael Wonder on 05 Sep 2018
Publication of final base-case ICERs (ICURs) by health technology assessment agencies
6 September 2018 - The Department of Health is dragging its heels on this issue. ...
Posted by Michael Wonder on 05 Sep 2018
Hand surgeon's career 'saved by gene-silencing drug'
5 September 2018 - Hand surgeon Carlos Heras-Palou said his career "would have been finished" in six months without the treatment. ...
Posted by Michael Wonder on 05 Sep 2018
Brad Hazzard’s call to stop free health care for tourists and visitors
6 September 2018 - All visitors to Australia will be required to have health insurance under a NSW government proposal ...